These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38505782)

  • 1. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
    Malik A; Malik M; Qureshi S
    Can Liver J; 2024 Feb; 7(1):40-53. PubMed ID: 38505782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis.
    Malik A; Nadeem M; Malik MI
    Clin J Gastroenterol; 2021 Dec; 14(6):1579-1586. PubMed ID: 34370218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Aramchol in patients with nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis.
    Malik A; Nadeem M; Amjad W; Malik MI; Javaid S; Farooq U; Naseem K; Khan A
    Prz Gastroenterol; 2023; 18(1):67-75. PubMed ID: 37007760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang LL; Zhang PH; Yan HH
    Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Hassan M; Al-Obaidi H; Karrick M; Merza N; Nawras Y; Saab O; Al-Obaidi AD; Merza F; Hashim HT; Al Zubaidi K; Al-Sabbagh D; Matbachi R; Noori Z; Amatul-Raheem H; Mansur S; Al Najafi O; Algodi M; Al Hamdany T; Kobeissy A
    Gastroenterology Res; 2024 Aug; 17(4):159-174. PubMed ID: 39247710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis.
    Li S; Duan F; Li S; Lu B
    Ann Hepatol; 2024; 29(2):101174. PubMed ID: 38579127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis.
    Jamil A; Chivese T; Elshaikh U; Sendall M
    BMC Public Health; 2024 Oct; 24(1):2701. PubMed ID: 39363272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis.
    de Avelar CR; Pereira EM; de Farias Costa PR; de Jesus RP; de Oliveira LPM
    World J Gastroenterol; 2017 Jul; 23(27):5004-5017. PubMed ID: 28785154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic fatty liver: a systematic review and meta-analysis.
    Wang T; Song J; Hu J; Feng S; Zhang H; Wang H; Li B
    Ann Palliat Med; 2021 Dec; 10(12):12969-12984. PubMed ID: 33691456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of resmetirom among patients with non-alcoholic steatohepatitis: a systematic review and meta-analysis.
    Mazhar S; Azhar A; Khan A; Shakil G; Kumari S; Devi D; Jawad S
    Ann Med Surg (Lond); 2024 Sep; 86(9):5447-5454. PubMed ID: 39239031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
    Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta-analysis of randomized controlled trials.
    Ardekani A; Tabrizi R; Maleki E; Bagheri Lankarani K; Heydari ST; Moradinazar M; Akbari M
    Food Sci Nutr; 2023 Jun; 11(6):2580-2588. PubMed ID: 37324909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF; Wang C; Yang T; Li S; Li KL; Li D
    Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR; Hernández-Saavedra D; An R; Rector RS
    Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.